Ouyang D, Hong T, Fu M, Li Y, et al. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer. Breast Cancer Res 2023;25:19.
PMID: 36765397